Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.07 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |